Lupin's myotonia treatment drug gets European Commission's approval

The approval makes NaMuscla the first treatment to be licensed throughout the EU for the symptomatic treatment of myotonia in adults with NOM disorders

from Latest News http://bit.ly/2CUDgfA
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share